Next Article in Journal
The Effect of Medical Device Regulations on Deploying a Lean Six Sigma Project
Next Article in Special Issue
Simultaneous Anaerobic Ammonium Oxidation and Electricity Generation in Microbial Fuel Cell: Performance and Electrochemical Characteristics
Previous Article in Journal
A Review of Generators and Power Converters for Multi-MW Wind Energy Conversion Systems
Previous Article in Special Issue
Degradation of Polyvinyl Chloride (PVC) Waste with Supercritical Water
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Tertiary Wastewater Treatment Technologies: A Review of Technical, Economic, and Life Cycle Aspects

by
Dimitris P. Zagklis
* and
Georgios Bampos
*
Department of Chemical Engineering, University of Patras, GR-26504 Patras, Greece
*
Authors to whom correspondence should be addressed.
Processes 2022, 10(11), 2304; https://doi.org/10.3390/pr10112304
Submission received: 28 September 2022 / Revised: 29 October 2022 / Accepted: 3 November 2022 / Published: 5 November 2022

Abstract

:
The activated sludge process is the most widespread sewage treatment method. It typically consists of a pretreatment step, followed by a primary settling tank, an aerobic degradation process, and, finally, a secondary settling tank. The secondary effluent is then usually chlorinated and discharged to a water body. Tertiary treatment aims at improving the characteristics of the secondary effluent to facilitate its reuse. In this work, through a literature review of the most prominent tertiary treatment methods, a benchmarking of their technical efficiency, economic feasibility, and environmental impact was carried out. The photo-Fenton method proved to be the most technically efficient process, significantly reducing the microbial load and pharmaceutical content (by 4.9 log and 84%, respectively) of the secondary effluent. Chlorination and UV irradiation exhibited the lowest treatment costs (0.004 EUR/m−3) and the lowest global warming potential (0.04 and 0.09 kg CO2eq. m−3, respectively). After all the data were aggregated, a decision-making tool was constructed in the form of a ternary diagram, which indicates the most appropriate tertiary treatment method according to the weight-per-process aspect (technical, economic, and environmental) selected by the user, with chlorination, UV irradiation, ozonation, microalgae cultivation, and constructed wetlands prevailing in the final results.

1. Introduction

Global population growth, as well as modern lifestyles, has resulted in an increase in the amount of produced sewage, thus making wastewater management urgent. According to United Nations estimations, the global population will reach ca. 11 billion by 2100, whereas other researchers estimate that the population will reach a lower peak earlier than 2100 [1]. In any case, human activity is expected to dramatically increase, followed by increased urban wastewater production.
Typically, wastewater can be classified as sewage when derived from domestic activities. Further categorization can divide sewage into blackwater, greywater, and yellow water, with the first corresponding to wastewater contaminated with human waste, the second to sewage derived from non-toilet units (e.g., showers) without being contaminated with human feces or urine, and the latter being polluted by urine collected from sewer channels [2,3,4]. Apart from domestic and industrial wastewater, hospitals, agricultural activity, and livestock farming can lead to aquatic environmental pollution, including contamination by emerging contaminants (ECs) (e.g., pharmaceuticals), posing a threat to both the environment and humans [5].
The most widespread sewage treatment method involves the activated sludge process. A typical wastewater treatment plant consists of a pretreatment step where grease and large solids are removed from the wastewater, followed by a primary settling tank. After most of the suspended solids are removed, the wastewater is led to the aerobic degradation process that implements the activated sludge. At this stage, most of the organic content is converted into carbon dioxide and microbial biomass. The effluent of the aerobic process is treated with a secondary settling tank that removes and partially recirculates the produced biomass. These are the steps that are typically included in such a process, with some also implementing a nitrification/denitrification process in the activated sludge process. The effluent of the secondary settling tank (secondary effluent) is then typically chlorinated and discharged into a water body.
Despite the fact that the aforementioned steps are enough to remove most of the organic content from wastewater, residual pollutants such as inorganic nutrients (mostly nitrogen and phosphorus), increased microbial content, and ECs can have a significant impact on the final treated wastewater recipients. Moreover, strict quality criteria need to be met before the treated water can be reused instead of ending up in a water recipient [6]. In this scope, several secondary effluent treatment methods have been developed and implemented, typically called tertiary treatment processes. Among the tertiary treatment methods, chlorination, ultraviolet irradiation, membrane filtration, constructed wetlands, microalgae cultivation, ozonation, and photo-Fenton processes have attracted significant research interest due to their low operational costs, as well as their high efficiency. Some indicative works related to tertiary treatment techniques are demonstrated in the present paper.
An effort was made by the authors to present the most important technical efficacy parameters, namely the ability of each tertiary process to reduce pathogens and remove inorganic nutrients and EC. Furthermore, to put the technical efficacy results into a sustainability perspective, data regarding the treatment costs and global warming potential were also collected. Most of the published literature assesses the technical efficacy of these methods, with a much smaller number of publications examining their economic and life cycle aspects, a fact that unfortunately causes a disparity between the data available for each examined aspect.

2. Tertiary Wastewater Treatment Technologies

2.1. Chlorination

Chlorination is a widely used disinfection method applied in the last stages of sewage treatment. As a strong oxidizer, chlorine reacts with organic compounds, but can also lead to the formation of harmful chlorinated byproducts with negative effects on human health and the environment [7]. Several studies have reported the potency of chlorination in disinfection. In the work of Decol et al. [8], a 2.5-log reduction in E. coli was achieved, whereas Francy et al. [9] reported a 0.7- to 2.6-log reduction in a number of microbiological indicators such as E. coli (highest log reduction) and viruses. Chlorination does not affect the nutrient content of secondary effluent (in terms of N and P), making this method unsuitable when the treated wastewater is led to recipients prone to eutrophication. Pharmaceutical compounds, on the other hand, are prone to oxidation from chlorine, with Li and Zhang [10] testing the effects of the chlorination of compounds, i.e., sulfamethoxazole, ciprofloxacin, norfloxacin, tetracycline, trimethoprim, and erythromycin, reporting a reduction of 43 to 73%. Regarding the economic aspect of chlorination, it is considered one of the cheapest tertiary methods, with a treatment cost of 0.0003 to 0.006 EUR/m3 [11,12,13]. Finally, due to its minimum energy needs, chlorination leads to very low greenhouse gas (GHG) emissions, with Walsh and Mellor [14] reporting GHG as low as 0.004 kg CO2 eq. m−3, whereas Pasqualino et al. [15] reported a slightly higher value of 0.07 kg CO2 eq. m−3.

2.2. Ultraviolet Irradiation

Ultraviolet technology, alone or combined with other degradation processes, has been extensively investigated as a tertiary treatment process. Zhang et al. examined the UV process coupled with H2O2 for secondary effluent treatment, achieving an ARG reduction equal to 3.48 log at pH 3.0 and 2.32 log at pH 7.0, whereas the cost was estimated at 0.296 USD/m3 [16]. The coupling of UV with H2O2 technology was studied in the removal of microcystin-RR by Qiao et al., with the reduction percentage of this pharmaceutical being 94.83% [17]. The combination of UV and the ozonation process by Chin and Bérubé in the treatment of surface water resulted in 50%, 80%, and 70% reductions in TOC, trihalomethane formation, and haloacetic acid formation, respectively [18].
A reduction of 100% for both diclofenac and bezafibrate was achieved when coupling UV irradiation with H2O2, as reported by De la Cruz et al., whereas the combination of three technologies UV/Fe2+/H2O2 resulted in a 100% elimination of diclofenac [19]. Moreover, Guo et al. examined the UV disinfection process over ARB and ARGs present in municipal sewage [20]. The reduction in bacteria resistant to erythromycin and tetracycline was found to be equal to 1.4 and 1.1 log, respectively.

2.3. Membrane Filtration

Membrane filtration methods include a diverse group of processes, with the most common ones being pressure-driven membranes. During pressure-driven membrane filtration, a pressure difference is imposed on the two sides of a semi-permeable membrane, with the kinds of solutes permeating the membrane, further defining the membrane types. Membranes with a pore size on a scale of 1 μm (microfiltration, MF) typically reject suspended solids. Ultrafiltration (UF) has a smaller pore diameter and can reject larger dissolved molecules. Membranes with a pore size on a scale of 1 nm fall within the nanofiltration (NF) group and can reject smaller dissolved molecules (typically up to 200 Da) and divalent ions. Finally, reverse osmosis (RO) has no pores and separation occurs through the different diffusion rates of the solutes in the polymer of the membrane. RO membranes can even reject monovalent ions [21].
An integrated pilot unit combining UF, RO, and electrooxidation to manage municipal sewage was introduced by Urtiaga et al. [22]. All the target compounds, namely naproxen, ofloxacin, furosemide, bezafibrate, and fenofibric acid, were rejected with a percentage higher than 99%. Cheng et al. studied the efficiency of an anaerobic MF system in the removal of some antibiotic resistance bacteria (ARB) and their associated ARGs found in municipal sewage and the microbial load reduction was equal to 2–3 log units [23]. The elimination of ARB and ARGs present in secondary wastewater effluent by employing a TiO2-modified polyvinylidene fluoride (PVDF) UF membrane was investigated by Ren et al. [24]. ARGs were removed at a rate of 98%.
Dolar et al. examined performance as it concerned the degradation of selected veterinary Phs present in pharmaceutical sewage using a laboratory and pilot scale RO/NF membrane treatment process [25]. The removal of TOC and COD was 70.8% and 35.4%, respectively, whereas the degradation percentage of the selected Phs ranged from 94% to 100% for the NF and RO membranes, respectively. Furthermore, Ho et al. examined palm oil mill effluent treatment by implementing graphene oxide (GO)/multi-walled carbon nanotube (MWCNTs) conductive membranes [26].
Treatment costs using membrane filtration can range from 0.4 to 1 EUR/m3 [27] and the produced emissions can range from 0.2 to 2.3 kg CO2 eq. m−3, with the total emissions depending on the number of membrane steps and the required transmembrane pressure [28,29].

2.4. Constructed Wetlands

Constructed wetlands (CW) have been used since the 1950s as a waste management option [30]. The premise of this wastewater treatment method is based on the naturally occurring processes involving vegetation, soil, and microorganisms in a controlled environment [30].
Breitholtz et al. [31] achieved a BOD reduction of 40%, whereas reductions in 92 pharmaceuticals (Phs) ranged between 42 and 52%. The treatment of wastewater derived from residential areas was investigated over horizontal flow constructed wetlands (HFCW), vertical flow constructed wetlands (VFCW), and biofilters by Adrados et al. [32]. According to their study, the TN reduction ranged from 21 to 85%. Younger and Henderson [33] reported 41%, 59%, and 66% reductions in BOD, P-PO4, and N-NH4, respectively, employing an innovative full-scale mine water/sewage cotreatment CW for polluted mine waters. The yield of a vertical up-flow CW for swine wastewater was studied by Huang et al. [34] with remarkable results. Reductions in COD, TN, N-NH4, and TP were 92.2%, 92.7%, 94.4%, and 97.8%, respectively, whereas the degradation of Phs ranged between 98.3% and 99.9%. The removal of various ECs (77.2%) and antibiotic resistance genes (ARGs) derived from landfill leachate was investigated by Yi et al. [35] by employing a full-scale horizontal subsurface flow CW. An integrated surface flow CW was employed over a 10-year period for the removal of ARGs found in domestic wastewater, as reported by Fang et al. [36]. The COD, BOD, TN, TP, and N-NH4 degradations were 70.8%, 75.2%, 60.2%, 55.6%, and 61.3%, respectively. Chen et al. examined the ARG (85.8%) and antibiotic eliminations from wastewater derived from residential areas using mesocosm-scale horizontal subsurface flow CWs [37]. VFCWs were applied for the removal of ciprofloxacin HCl, oxytetracycline HCl, and sulfamethazine from swine sewage achieving elimination rates of 85%, 95%, and 73% for each of the aforementioned antibiotics, as found by Liu et al. [38]. The elimination of ARGs from municipal wastewater was studied by Nõlvak et al. [39] by employing horizontal subsurface flow CWs, achieving a 92% and 25% removal of BOD and TN, respectively. Chen et al. studied the effect on the degradation of antibiotics and ARGs of domestic sewage by employing six mesocosm-scale CWs [40]. The removal rates of COD, TOC, TN, and N-NH3 were 80.2%, 80.3%, 54.7%, and 44%, respectively, whereas the total removal of all detected antibiotics was 98.6%. A 62% reduction in the rate of tet genes and a 90% average total removal rate of oxytetracycline and difloxacin antibiotics from swine sewage were achieved by applying a VFCW by Huang et al. [41].
Ledón et al. found a 90% reduction in the BOD rate from domestic wastewater by employing horizontal subsurface flow (HSSF) CW with the HSSF pretreatment cost being equal to 1903 USD/p.e, whereas the GHG emissions ranged between 3.8 and 4.7 kg CO2-eq/kg for BOD5 [42]. The coupling of microbial fuel cell (MFCs) technology with a conventional HSSF CW was investigated for municipal wastewater treatment by Corbella et al., achieving a remarkable 85% BOD reduction, where the cost of a conventional CW was estimated at 430 EUR/p.e [43]. Winery sewage treatment employing various scenarios of CW operations was examined by Flores et al., with the GHG emissions derived from the LCA being 1.3 kg CO2-eq/m3 [44]. Significant variations in costs were observed via life cycle costing (LCC) analysis of two different small-scale WWTPs coupled with CW technology for the treatment of wastewater produced by a student residential building and its coffee shop located in Brazil [45]. The cost of the scenario implementing a mobile CW (2.42 × 104 kg CO2-eq) was found to be higher than that of the scenario using a decentralized VFCW (1.03 × 104 kg CO2-eq) for wastewater treatment by Lakho et al. [46]. Pan et al. investigated the treatment of wastewater produced by the residential area of Changzhou in China using a vertical subsurface flow CW system, achieving 96% and 83% reductions in BOD and N-NH4, respectively, whereas the total GHG emissions were estimated at 38.83 kg CO2-eq/d [47]. A subsurface flow CW system was implemented for blackwater and greywater treatment coming from a rural area in Southern Brazil and showed an impressive COD, BOD, TKN, N—NH3, and total P reduction, as described by Lutterbeck et al. [48]. The LCA revealed GHG emissions of 1.33 × 103 kg CO2 eq. Finally, Garfí et al. examined the performance of a combined VFCW and HFCW system for the treatment of sewage produced by small rural areas [49]. The BOD reduction was 89%, the capital cost was 210.36 EUR/p.e., the operational and maintenance costs were 0.4 EUR/m3, and the GHG emissions were ca. 990 g CO2/m3water.

2.5. Microalgae

WWTPs based on microalgae have gained significant attention since they combine environmentally friendly tertiary treatment technology with enhanced biomass production [50]. Two different microalgae-based WWTPs were compared considering their performance in agro-industrial sewage treatment, as reported by Magalhães and co-workers [50]. Both proposed WWTPs were examined for wastewater treatment, as well as microalgae biomass production. The first system was a bubble column photobioreactor (PBR), whereas the second was a high-rate pond (HRP). The COD reduction of the former was 54.3%, whereas the reduction percentage of the latter was 47.7%. The removal rates of N-NH4 and P were found to be complete in the case of the PBR and were 59.5% and 100%, respectively, in the case of the HPR, highlighting the superior performance of the PBR. Silambarasan et al. studied the performance of coupling microalgae (Scenedesmus sp. and Chlorella sp.) with lipid augmentation in order to remove nutrients from domestic sewage [51]. The reduction percentages of COD, TOC, TN, N-NH4+, N-NO3, and PO43− were estimated at 83%, 86%, 94%, 98%, 96%, and 95%, respectively.
Marangon et al. compared the environmental impact of two different scenarios for domestic sewage treatment [52]. According to the first scenario, a high-rate algal pond (HRAP) treatment system resulted in 0.1 kg CO2eq GHG emissions, whereas following the second scenario based on a hybrid reactor formed by an HRAP and a BR, the emissions corresponded to 0.19 kg CO2eq. Li and co-workers investigated the treatment of municipal sewage by a non-separated nutrient resource derived from municipal wastewater and integrated in order to facilitate biofuel production from microalgae [53]. The GHG emitted from the proposed process were 20,881 kg CO2eq/y.

2.6. Ozonation

Ozonation was used for wastewater treatment purposes in 1906 in Paris, France [54]. In ozonation processes, ozone reacts with organic contaminants and degrades them but can form intermediary toxic products, and its low water solubility leads to low process efficiency [54]. This process has been examined in the literature as a tertiary treatment method, producing great results for the microbial load and the pharmaceuticals removed, but did not significantly affect the nutrient content of the secondary effluent. More specifically, Lamba and Ahammad [55], reported a 4 log reduction in coliforms, whereas Nasuhoglu et al. [56], Shi et al. [57], and Maniakova et al. [58], reported a 2.2- to 5.3-log reduction in coliforms, E. coli, Salmonella, and Enterococcus. Regarding pharmaceutical removal, Liu et al. [59] found that ozonation was capable of removing a range of pharmaceuticals by 5 to 80%. Antoniou et al. [60] also reported a removal of 70 to 100% for carbamazepine, naproxen, beclomethasone, and memantine. Regarding the treatment costs, 0.03 EUR/m3 has been reported in the literature [61], with a global warming potential of 0.025 to 0.3 kg CO2 eq. m−3.

2.7. Photo-Fenton

Among the various advanced oxidation processes (AOPs), the Fenton oxidation process has gained significant attention, mostly because of its low operational costs [62]. The photo-Fenton process was employed in order to be studied for the removal of sulfamethazine, resulting in complete degradation of this antibiotic, whereas the TOC reduction was 56%, as reported by Pérez-Moya et al. [62]. A 100% elimination of amoxicillin and an 81% TOC removal were obtained by implementing the photo-Fenton process as presented by Trovó et al. [63]. The degradation of 22 micropollutants present in municipal wastewater was investigated by employing a photo-Fenton (UV254/H2O2/Fe) process, as shown by De la Cruz et al. [19]. The average percentage concerning the removal of all 22 pollutants was 80%.
The solar photo-Fenton process was quite effective for ARB and ARG removal from urban sewage, as mentioned by Giannakis et al. [64]. Various Phs, namely ofloxacin, carbamazepine, flumequine, ibuprofen, and sulfamethoxazole, were found to be almost completely removed from municipal sewage when coupling NF and solar photo-Fenton technology, as reported by Miralles-Cuevas et al. [65]. Quite interesting is the work of Elmolla and Chaudhuri, who combined the photo-Fenton process with a sequencing batch reactor (SBR) to study performance concerning the treatment of antibiotic wastewater [66]. They achieved an 89% reduction in soluble COD.
Reductions in the Phs present in wastewater produced by a Spanish pharmaceutical industrial unit were investigated by considering the environmental impact of employing an LCA over heterogeneous and homogeneous Fenton processes, as reported by Rodríguez and co-workers [67]. The heterogeneous Fenton process exhibited lower GHG emissions of 0.04 kg CO2eq. An LCA study was performed by Pesqueira et al. of various solar-based treatments including solar circumneutral photo-Fenton (SPF) [68]. The GHG emissions of the latter were estimated at 0.331 kg CO2eq. The emitted GHG of 554 kg CO2eq/1000 m3 as it concerns the operation of a solar photo-Fenton process at acidic pH for municipal wastewater treatment were found to be lower compared to systems operating at neutral pH, as presented by Gallego-Schmid and co-workers [69].
A semi-industrial solar photo-Fenton reactor was investigated by Foteinis et al. concerning the environmental sustainability of the proposed process over real wastewater effluent derived from a pharmaceutical laboratory [70]. The TOC reduction was found to be 79%, whereas the GHG emissions obtained from the LCA corresponded to 2.71 kg CO2eq m−3. Photo-Fenton processes in compound parabolic concentrator-type solar reactors have attracted significant interest recently, which is mostly attributed to their enhanced performance over the degradation of recalcitrant pollutants [71]. As mentioned in the analysis performed by Belalcázar-Saldarriaga and co-workers of the above-mentioned process employed for the degradation of acid orange 52 dye (AO52), the obtained COD and TOC reduction percentages were 55% and 35%, respectively, and the GHG emitted from the system operation were 0.762 kg CO2eq/m3 wastewater [71].

3. Benchmarking of Tertiary Wastewater Treatment Technologies

The data collected from the literature regarding the aforementioned methods are presented in Appendix A and summarized in Table 1. As can be observed in Table 1, the different tertiary treatment methods exhibited different strengths and weaknesses in the examined aspects. The physicochemical and advanced oxidation methods had a significant impact on the microbial load of the secondary effluent, whereas the biological methods did not exhibit microbial load reductions (or this was not reported at all in the examined literature). On the other hand, the biological processes were the only ones with significant nutrient removal through their assimilation with the produced biomass. Regarding the presence of pharmaceuticals, all the examined tertiary methods showed significant reductions. Regarding the economic aspect, the simpler (and more widespread) methods, such as chlorination, UN irradiation, and ozonation, had the lowest treatment costs. Finally, the GWP of the examined methods seems to follow a similar trend to their energy consumption, with the energy-intensive processes, i.e., membrane filtration, exhibiting the highest GHG emissions.
In order to facilitate a comparison of the different tertiary treatment methods investigated, a scoring methodology was implemented, with a score given for the three aspects (technical, economic, and life cycle) for each treatment method. In this way, the performance of each tertiary treatment method could be put into perspective and easily compared with that of the other examined processes. The scoring system ranged from 0% (worst score) to 100% (best score), with different normalization steps being needed for each aspect. Here, it should be noted that despite making the results of the literature review more comprehensible, the necessary assumptions for the scoring step, such as using data for the removal of specific pathogens or pharmaceuticals for each tertiary treatment method, increased the uncertainty. For the highest accuracy, the reader should refer to the raw data extracted from the literature.
Regarding the technical aspect, the three subcategories of microbial load, nutrient, and pharmaceutical reductions were considered to contribute equally to the average technical aspect score. After normalizing the microbial reduction data by dividing by the highest value, an average reduction was calculated for each method using the microbial, nutrient, and pharmaceutical reductions. Finally, in order to have the technical aspect scores ranging from zero to one hundred, the average reduction values were normalized a second time by subtracting the lowest average reduction value and dividing by the highest average reduction value.
Because the economic and life cycle aspects had a negative impact on the evaluation of the processes, the values used for scoring were the comparison of the methods and the worst results for each criterion. For example, constructed wetlands had the highest treatment cost amongst the processes examined, whereas chlorination and UV had the lowest. The value used for scoring the economic aspect of microalgae was 0.784 − 0.291 = 0.493 EUR/m3, which was then normalized by dividing by the difference between the highest value and the minimum value among the processes. This way, the worst-performing method had a score of zero and the best-performing method had a score of one hundred after normalization. The three obtained scores for each aspect examined are presented in Figure 1.
Because of the complex nature of choosing the most appropriate tertiary treatment method, since each method had certain strengths and weaknesses, the weight given to each of the three examined aspects was decided. In order to facilitate this process, a ternary diagram was constructed, with its three axes corresponding to the different weights to be given to each aspect (Figure 2). Each point in Figure 2 denotes the method with the highest weighted score for the three corresponding weight values. The ternary diagram was constructed by calculating the overall score of all the examined methods at each point and indicating the tertiary method with the highest overall score. The overall score for each method at each point was calculated using the three weights for the three examined aspects (corresponding to the coordinates of the points on the diagram) and the score for each aspect (as depicted in Figure 1). For example, for the points 0.2, 0.6, 0.2 (technical, economic, and life cycle) in the ternary plot, the overall score of all the methods was calculated using the formula 0.2 × Technical aspect score + 0.6 × Economic aspect score + 0.2 × Life cycle aspect score. The resulting scores for all the methods at this point in the plot were compared and the UV method was proven to have the highest overall score. This process was repeated for all the points in Figure 2 in increments of 0.025, calculating a total of 860 sets of overall scores. In this way, the best-performing (in terms of overall score) methods were determined and are depicted in Figure 2. The fact that not all the examined tertiary treatment methods appear in the final plot corresponds to the fact that the missing methods did not exhibit the highest overall score amongst the examined methods at any point in the plot. The final plot can be used to indicate the tertiary method with the highest overall score for a set of weights determined by the user, corresponding to the importance of the technical, economic, and life cycle aspects of the application under investigation.

4. Conclusions

Many options for tertiary treatment have been examined in the literature, with each treatment process exhibiting different positive and negative points. The first step of the analysis presented herein was the aggregation of data regarding the technical, economic, and environmental impact of each process. This step had the fewest assumptions, as the data were reported as extracted from the literature, but a further aggregation of the results could facilitate a comparison of the tertiary treatment methods examined. As a next step, the data were normalized (assuming the equivalent significance of microbial load, nutrient, and pharmaceutical reductions) and scored. Despite the fact that this process facilitated a comparison of the examined methods, some applications may have attributed higher importance to one technical aspect, for example, when the water recipient was prone to eutrophication or if the sewage derived from a hospital with a high pharmaceutical concentration. The final step was the construction of the ternary diagram illustrating the tertiary treatment method with the highest weighted score for each weight set chosen by the user. This tool can be used to quickly illustrate the strengths and weaknesses of the examined methods and also for decision making in a typical tertiary treatment process, but as previously stated, when specific challenges need to be overcome, directly examining the data aggregated from the literature would be more suitable. UV, ozonation, and chlorination dominated the optimal tertiary treatment methods according to Figure 2, followed by microalgae cultivation and constructed wetlands. The most important advantage of UV and chlorination appears to be their lower treatment costs and low GHG emissions, whereas ozonation exhibited increased efficiency in microbial load and pharmaceutical reductions with moderate treatment costs. The increased treatment costs and GHG emissions of membrane filtration and photo-Fenton did not allow for their assessment as optimal tertiary methods under any set of weights, as seen in Figure 2. It should be noted that these results were dependent on the implemented methodology, and the high efficiency of both the membrane filtration and photo-Fenton methods in the removal of pathogens and pharmaceuticals can be of high value in cases where increased treatment efficiency is required. Through the analysis presented herein, the complementarity of different tertiary treatment methods is illustrated, facilitating their combination in multi-step processes for the removal of all contaminants (i.e., combining biological and physicochemical or advanced oxidation methods).

Author Contributions

Conceptualization, D.P.Z. and G.B.; methodology, D.P.Z.; validation, G.B.; investigation, D.P.Z. and G.B.; data curation, D.P.Z. and G.B.; writing—original draft preparation, D.P.Z. and G.B.; writing—review and editing, D.P.Z. and G.B.; All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

Data are contained within the article in Appendix A.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

AO52acid orange 52
AOPsadvance oxidation processes
ARBanaerobic resistant bacteria
ARGantibiotic resistance genes
BODbiochemical oxygen demand
BRbiofilm reactor
CODchemical oxygen demand
CWconstructed wetlands
ECemerging contaminants
GHGgreenhouse gases
GOgraphene oxide
HFCWhorizontal flow constructed wetlands
HRAPhigh-rate algal pond
HRPhigh-rate pond
HSSFhorizontal subsurface flow
LCClife cycle costing
MFmicrofiltration
MFCsmicrobial fuel cells
MWCNTsmulti-walled carbon nanotubes
NFnanofiltration
PBRphotobioreactor
PVDFpolyvinylidene fluoride
ROreverse osmosis
SBRsequencing batch reactor
SPFsolar photo-Fenton
TOCtotal organic carbon
UFultrafiltration
UVultraviolet
VFCWvertical flow constructed wetlands

Appendix A

Table A1. Literature data used for scoring the chlorination method.
Table A1. Literature data used for scoring the chlorination method.
Process InformationTechnicalEconomic
(Cost EUR/m3)
Life Cycle
(kg CO2 eq./m3)
Ref.
Microbial
(Log Reduction)
Nutrients
(% Reduction)
Pharmaceuticals
(% Reduction)
Sulfamethoxazole 220 ng/L 73 [10]
Ciprofloxacin 153 ng/L 66 [10]
Norfloxacin 92 ng/L 50 [10]
Tetracycline 86 ng/L 39 [10]
Trimethoprim 155 ng/L 65 [10]
Erythromycin 273 ng/L 43 [10]
Diclofenac 40 μg/L 97 [72]
Ibuprofen 40 μg/L 0 [72]
Clofibric acid 40 μg/L 5 [72]
Naproxen 40 μg/L 11 [72]
Gemfibrozil 40 μg/L 45 [72]
Mefenamic acid 40 μg/L 12 [72]
E. coli 3.7 Log CFU/100 mL2.5 [8]
E. coli 4.34 Log CFU/100 mL2.57 [9]
Enterococci 3.46 Log CFU/100 mL1.18 [9]
Fecal coliforms 4.57 Log CFU/100 mL2.34 [9]
F-specific coliphage 2.33 Log CFU/100 mL0.71 [9]
Somatic coliphage 3.92 Log CFU/100 mL1.68 [9]
Adenovirus 0.97 Log CFU/100 mL0.81 [9]
Norovirus 0.74 Log CFU/100 mL0.74 [9]
Coliforms 4 Log CFU/100 mL4 [55]
Antib. Resist. Genes 6 Log1.97 [13]
E. coli 7 Log CFU/mL5 [57]
0.0003 [11]
0.005 [12]
0.006 [13]
0.046[73]
0.007[15]
0.004[14]
Table A2. Literature data used for scoring the UV method.
Table A2. Literature data used for scoring the UV method.
Process InformationTechnicalEconomic
(Cost EUR/m3)
Life Cycle
(kg CO2 eq./m3)
Ref.
Microbial
(Log Reduction)
Nutrients
(% Reduction)
Pharmaceuticals
(% Reduction)
E. coli 5 × 105 CFU/100 mL4 [74]
E. coli 7.7 Log × 10 CFU/L3.82 [9]
Enterococci 8.56 Log × 10 CFU/L3.38 [9]
Fecal coliforms 8.26 Log × 10 CFU/L3.89 [9]
F-specific coliphage 6.4 Log × 10 CFU/L1.17 [9]
Somatic coliphage 7.36 Log × 10 CFU/L2.98 [9]
Adenovirus 2.73 Log gc/L0.24 [9]
Coliforms 5 Log CFU/mL4 [55]
Antib. Resist. Genes 6 Log1 [13]
Antib. Resist. Genes 5 Log copies/L2.5 [20]
E. coli 2 × 107 CFU/mL5.1 [57]
Sulfamethoxazole 250 ng/L 100 [75]
Trimethoprim 90 ng/L 100 [75]
Erythromycin 200 ng/L 100 [75]
Acetaminophen 0.1 mM, caffeine 0.12 mM, antipyrine 0.05 mM, doxycycline 0.03 mM, ketorolac 0.05 mM 100 [76]
Atrazine diuron, alachlor, pentachlorophenol 1 mg/L 72 [76]
Boldenone 6.57 μM 98 [76]
BPA 60 μM 22 [76]
Butylparaben 8 × 10−5 M 97 [76]
Carbamazepine 3 μΜ 52 [76]
Chlorfenvinphos 91 [76]
Ciprofloxacin 99 [76]
Chloromycetin 10 mg/L 80 [76]
Clofibric acid 10 mg/L 98 [76]
Cyclophosphamide 10 μg/L 28 [76]
Cytarabine 10 mg/L 10 [76]
Diatrizoate 50 μM 97 [76]
Diclofenac 20 mg/L 74 [76]
Diphenhydramine 5 μM 26 [76]
Doxycycline 5 × 10−5 M 27 [76]
E1 20 mg/L 69 [76]
E2 20 mg/L 59 [76]
EE2 37 [76]
Hydrochlorothiazide 1 μM 59 [76]
Ibuprofen 10−4 M 74 [76]
Iopromide 53 [76]
Iohexol 3 μΜ 12 [76]
Irinotecan 10 µg/L 18 [76]
Isoproturon 1 mg/L 12 [76]
Ketoprofen 50 µM 99 [76]
Mefenamic acid 5.5 Log M 56 [76]
Melatonin 20 mg/L 32 [76]
Metoprolol 5 × 10−4 M 69 [76]
Metronidazole 6 μM 55 [76]
Naproxen 3 μM 65 [76]
NDMA 1 mM 100 [76]
Norfloxacin 5 × 10−5 M 55 [76]
Oxtetracycline 93 [76]
Phenazone 5 μM 96 [76]
Phenytion 5 μM 88 [76]
Primidone 50 µM 9 [76]
Propranolol 100 mg/L 61 [76]
Sulfadimethoxine 3.2 mM 99 [76]
Sulfamethoxazole 10 mg/L 83 [76]
Tamoxifen 10 µg/L 43 [76]
TCE 8.14 × 10−3 mol/L 95 [76]
Tibetene 0.03 mM 87 [76]
Bezafibrate 112 ng/L 0 [19]
Metformin 1736 ng/L 27 [19]
Carbamazepine 333 ng/L 48 [19]
Gabapentin 1508 ng/L 0 [19]
Diclofenac 925 ng/L 96 [19]
Ketoprofen 40 ng/L 97 [19]
Naproxen 372 ng/L 70 [19]
Primidone 65 ng/L 3 [19]
Atenolol 320 ng/L 0 [19]
Metoprolol 255 ng/L 0 [19]
Ciprofloxacin 72 ng/L 56 [19]
Clarithromycin 187 ng/L 10 [19]
Sulfamethoxazole 355 ng/L 3 [19]
Trimethoprim 31 ng/L 0 [19]
Iohexol 4313 ng/L 16 [19]
Iomeprol 5806 ng/L 0 [19]
Benzotriazole 6736 ng/L 18 [19]
Atrazin 25 ng/L 58 [19]
Isoproturon 4 ng/L 0 [19]
Mecoprop 365 ng/L 0 [19]
Terbutryn 23 ng/L 39 [19]
0.00001 [11]
0.00644 [13]
0.0063 [13]
0.013[73]
0.026[15]
0.22[77]
Table A3. Literature data used for scoring the membrane filtration method.
Table A3. Literature data used for scoring the membrane filtration method.
Process InformationTechnical AspectEconomic Aspect
(Cost EUR/m3)
Life Cycle
(kg CO2 eq./m3)
Ref.
Microbial
(Log Reduction)
Nutrients
(% Reduction)
Pharmaceuticals
(% Reduction)
UF enterococcus 1.87 × 105 CFU/100 mL5 [6]
UF other coliforms 5.05 × 104 CFU/100 mL2 [6]
UF N 3.62 mg/L 10 [6]
UF P 1.86 mg/L 9 [6]
UF K 16.15 mg/L 0 [6]
NF-90 2 μg/L 73 [78]
NF-200 neutral PhACs 65 μg/L 70 [78]
NF-200 ionic PhACs 65 μg/L 94 [78]
NF-90 neutral 65 μg/L 97 [78]
NF-90 ionic 65 μg/L 99 [78]
NF-90 65 μg/L 73 [78]
UF 2000 0.5 mg/L 70 [78]
UF-NF90 750 μg/L 50 [78]
NF 270 RO 2 μg/L 95 [78]
NF 150-RO 100 ng/L 95 [78]
NF 200 100 ng/L 80 [78]
UF 8000-NF 600 10 ng/L 60 [78]
UF 8000 10 ng/L 30 [78]
NF 90-RO 10 mg/L 99 [78]
NF 200 21 ng/L 100 [78]
NF 270 10 mg L 60 [78]
NF270 800 μg/L 58 [78]
NF90 750 μg/L 97 [78]
RO 0.55 mg/L 100 [78]
NF90 10 mg/L 90 [78]
NF270 10 mg/L 61 [78]
NF90 0.5 mg/L 98 [78]
NF270 0.5 mg/L 71 [78]
RO 0.5 mg/L 89 [78]
NF90 5400 μg/L 77 [78]
NF270 5400 μg/L 58 [78]
RO 5400 μg/L 93 [78]
UF-Atenolol 778 ng/L 0 [22]
UF-Bezafibrate 208 ng/L 21 [22]
UF-Caffeine 17,725 ng/L 0 [22]
UF-Fenofibric acid 139 ng/L 0 [22]
UF-Furosemide 1302 ng/L 17 [22]
UF-Gemfibrozil 18,504 ng/L 71 [22]
UF-Hydrochlorothiazide 16,628 ng/L 90 [22]
UF-Ibuprofen 2514 ng/L 1 [22]
UF-4-AAA 7364 ng/L 0 [22]
UF-Naproxen 2672 ng/L 12 [22]
UF-Nicotine 10,954 ng/L 63 [22]
UF-Ofloxacin 94 ng/L 0 [22]
RO-Atenolol 1044 ng/L 100 [22]
RO-Bezafibrate 164 ng/L 100 [22]
RO-Caffeine 6288 ng/L 99 [22]
RO-Fenofibric acid 194 ng/L 100 [22]
RO-Furosemide 811 ng/L 100 [22]
RO-Gemfibrozil 1035 ng/L 99 [22]
RO-Hydrochlorothiazide 239 ng/L 95 [22]
RO-Ibuprofen 574 ng/L 97 [22]
RO-4-AAA 4472 ng/L 99 [22]
RO-Naproxen 2583 ng/L 98 [22]
RO-Nicotine 75 ng/L 76 [22]
RO-Ofloxacin 87 ng/L 95 [22]
Including RO 0.46 [27]
FO-NF 0.96 [27]
UF-RO 0.4 [27]
UF 0.45 [27]
UF-RO 0.8 [27]
UF-RO 2.32[29]
NF 0.2[28]
UF 0.25[77]
UF 0.40[73]
MF-RO 0.89[73]
UF-RO 0.91[73]
Table A4. Literature data used for scoring the constructed wetlands method.
Table A4. Literature data used for scoring the constructed wetlands method.
Process InformationTechnical AspectEconomic Aspect
(Cost EUR/m3)
Life Cycle
(kg CO2 eq./m3)
Ref.
Microbial
(Log Reduction)
Nutrients
(% Reduction)
Pharmaceuticals
(% Reduction)
16 s rDNA, intI1, and tet genes1.78 [34]
14 antibiotic resistance genes0.50 [36]
ARGs 8–9 Log of copies/mL0.49 [40]
N 23.4 mg/L 5 [31]
P 0.2 mg/L 0 [31]
N 29.3 mg/L 35 [31]
P 0.2 mg/L 50 [31]
N 17.3 mg/L 39 [31]
P 0.2 mg/L 50 [31]
N 1.39 mg/L 66 [33]
P 3 mg/L 46 [33]
N 84.4 mg/L 63 [34]
P 28.2 mg/L 92 [34]
N 35 mg/L 46 [40]
N 72 mg/L 99 [79]
P 11.7 mg/L 97 [79]
65 pharmaceuticals 4.3 μg/L 64 [31]
55 pharmaceuticals 300 ng/L 43 [31]
53 pharmaceuticals 50 [31]
56 pharmaceuticals 190 ng/L 32 [31]
6 pharmaceuticals 7.6–150 μg/L 93 [80]
Antibiotics 300 ng/L 58 [40]
Pharmaceuticals 50–200 ng/L 59 [79]
1.224 [45]
0.729 [45]
0.4 [49]
0.129[73]
0.432[42]
0.646[42]
0.911[42]
0.5[42]
0.26[47]
0.7[49]
Table A5. Literature data used for scoring the microalgae.
Table A5. Literature data used for scoring the microalgae.
Process InformationTechnicalEconomic
(Cost EUR/m3)
Life Cycle
(kg CO2 eq./m3)
Ref.
Microbial
(Log Reduction)
Nutrients
(% Reduction)
Pharmaceuticals
(% Reduction)
N 40 mg/L 55 [81]
P 80 mg/L 15 [81]
N 52 mg/L 82 [82]
P 8.5 mg/L 95 [82]
N 18 mg/L 100 [83]
P 1.4 mg/L 84 [83]
N 46 mg/L 94 [51]
P 5.5 mg/L 95 [51]
Metronidazole 5 μM 100 [84]
Florfenicol 46 mg/L 97 [84]
Enrofloxacin 1 mg/L 23 [84]
Tetracycline 100 μg/L 99 [84]
Methyl parathion 20 mg/L 80 [84]
Trimethoprim, Sulfamethoxazole, Triclosan 1.6 ng/L, 360 ng/L, 8 ng/L 44 [84]
7-amino cephalosporanic acid 100 mg/L 70 [84]
Cefradine 100 mg/L 94 [84]
β-estradiol 93 [84]
17 α-estradiol, 17 β-estradiol, Estrone, Estriol 5 μg/L 90 [84]
Sulfathiazole, Sulfapyridine, Sulfamethazine, Sulfamethoxazole, Tetracycline, Oxytetracycline 200 μg/L 47 [84]
Norfloxacin mg/L 37 [84]
0.42 [49]
0.162 [85]
0.6[49]
0.336[86]
Table A6. Literature data used for scoring the ozonation method.
Table A6. Literature data used for scoring the ozonation method.
Process InformationTechnicalEconomic
(Cost EUR/m3)
Life Cycle
(kg CO2 eq./m3)
Ref.
Microbial
(Log Reduction)
Nutrients
(% Reduction)
Pharmaceuticals
(% Reduction)
Coliforms 4 Log CFU/100 mL4 [55]
Coliforms 5 Log MPN/100 mL2.5 [56]
Coliforms 5 Log MPN/100 mL2.2 [56]
Coliforms 7 Log MPN/100 mL4.8 [56]
E. coli 7.3 Log CFU/mL5.3 [57]
E. coli 4 Log CFU/mL2.2 [58]
Salmonella 2.9 Log CFU/mL2.2 [58]
Enterococcus 3 Log CFU/mL2.2 [58]
Carbamazepine 75 [59]
Alachlor 20 [59]
Bisphenol A 60 [59]
Atrazine 5 [59]
Pentachlorophenol 35 [59]
17-α thinylestradiol 80 [59]
Carbamazepine 1 μg/L 100 [60]
Naproxen 1 μg/L 100 [60]
Beclomethasone 1 μg/L 70 [60]
Memantine 1 μg/L 80 [60]
0.03 [61]
0.03 [61]
0.025[87]
0.25[88]
0.3[28]
0.3[89]
Table A7. Literature data used for scoring the Photo-Fenton method.
Table A7. Literature data used for scoring the Photo-Fenton method.
Process InformationTechnicalEconomic
(Cost EUR/m3)
Life Cycle
(kg CO2 eq./m3)
Ref.
Microbial
(Log Reduction)
Nutrients
(% Reduction)
Pharmaceuticals
(% Reduction)
S. aureus 6 Log CFU/mL6 [64]
MRSA ATCC 29213 6 Log CFU/mL6 [64]
E. coli 6 Log CFU/mL6 [64]
K. pneumoniae 6 Log CFU/mL6 [64]
MSSA 1112 6 Log CFU/mL6 [64]
MSSA 1112 RifR 6 Log CFU/mL6 [64]
MSSA 1112 CipR 6 Log CFU/mL6 [64]
MSSA 133 6 Log CFU/mL6 [64]
MSSA 133 CipR 6 Log CFU/mL6 [64]
MRSA PC1 6 Log CFU/mL6 [64]
VISA PC# 6 Log CFU/mL6 [64]
E. coli 4 Log CFU/mL1 [58]
Salmonella 2.9 Log CFU/mL2 [58]
Enterococcus 3 Log CFU/mL0 [58]
Sulfamethazine 50 mg/L 100 [62]
Amoxicillin 50 mg/L 100 [63]
Bezafibrate 112 ng/L 0 [19]
Gemfibrozil 9 ng/L 96 [19]
Metformin 1736 ng/L 63 [19]
Carbamazepine 333 ng/L 94 [19]
Gabapentin 1508 ng/L 77 [19]
Diclofenac 925 ng/L 100 [19]
Ketoprofen 40 ng/L 97 [19]
Naproxen372 ng/L 97 [19]
Primidone 65 ng/L 77 [19]
Atenolol 320 ng/L 87 [19]
Metoprolol 255 ng/L 90 [19]
Ciprofloxacin 72 ng/L 61 [19]
Clarithromycin 187 ng/L 76 [19]
Sulfamethoxazole 355 ng/L 82 [19]
Trimethoprim 31 ng/L 88 [19]
Iohexol 4313 ng/L 94 [19]
Iomeprol 5806 ng/L 87 [19]
Benzotriazole 6736 ng/L 95 [19]
Atrazin 25 ng/L 82 [19]
Isoproturon 4 ng/L 32 [19]
Mecoprop 365 ng/L 93 [19]
Terbutryn 23 ng/L 83 [19]
Ofloxacin 110 μg/L 100 [65]
Carbamazepine130 μg/L 96 [65]
Flumequine 145 μg/L 98 [65]
Ibuprofen 130 μg/L 95 [65]
Sulfamethoxazole 140 μg/L 90 [65]
0.25 [90]
0.56 [90]
0.331[68]
0.554[69]
0.762[71]

References

  1. Adam, D. How far will global population rise? Researchers can’t agree. Nature 2021, 597, 462–465. [Google Scholar] [CrossRef] [PubMed]
  2. Deaver, J.A.; Kerr, C.A.; Popat, S.C. Primary sludge-based blackwater favors electrical current over methane production in microbial electrochemical cells. J. Water Process Eng. 2022, 47, 102848. [Google Scholar] [CrossRef]
  3. Wallin, J.; Knutsson, J.; Karpouzoglou, T. A multi-criteria analysis of building level graywater reuse for personal hygiene. Resour. Conserv. Recycl. Adv. 2021, 12, 200054. [Google Scholar] [CrossRef]
  4. Saliu, T.D.; Ali, J.; Ololade, I.A.; Oladoja, N.A. Preparation and characterization of a decentralized modular yellow water nutrient recovery system. J. Environ. Manag. 2020, 276, 111345. [Google Scholar] [CrossRef] [PubMed]
  5. Tran, N.H.; Reinhard, M.; Gin, K.Y.-H. Occurrence and fate of emerging contaminants in municipal wastewater treatment plants from different geographical regions-a review. Water Res. 2018, 133, 182–207. [Google Scholar] [CrossRef]
  6. Zagklis, D.; Katrivesis, F.K.; Sygouni, V.; Tsarouchi, L.; Tsigkou, K.; Kornaros, M.; Paraskeva, C.A. Recovery of Water from Secondary Effluent through Pilot Scale Ultrafiltration Membranes: Implementation at Patras’ Wastewater Treatment Plant. Membranes 2021, 11, 663. [Google Scholar] [CrossRef]
  7. Albolafio, S.; Marín, A.; Allende, A.; García, F.; Simón-Andreu, P.J.; Soler, M.A.; Gil, M.I. Strategies for mitigating chlorinated disinfection byproducts in wastewater treatment plants. Chemosphere 2022, 288, 132583. [Google Scholar] [CrossRef]
  8. Tombini Decol, L.; López-Gálvez, F.; Truchado, P.; Tondo, E.C.; Gil, M.I.; Allende, A. Suitability of chlorine dioxide as a tertiary treatment for municipal wastewater and use of reclaimed water for overhead irrigation of baby lettuce. Food Control 2019, 96, 186–193. [Google Scholar] [CrossRef]
  9. Francy, D.S.; Stelzer, E.A.; Bushon, R.N.; Brady, A.M.G.; Williston, A.G.; Riddell, K.R.; Borchardt, M.A.; Spencer, S.K.; Gellner, T.M. Comparative effectiveness of membrane bioreactors, conventional secondary treatment, and chlorine and UV disinfection to remove microorganisms from municipal wastewaters. Water Res. 2012, 46, 4164–4178. [Google Scholar] [CrossRef]
  10. Li, B.; Zhang, T. Mass flows and removal of antibiotics in two municipal wastewater treatment plants. Chemosphere 2011, 83, 1284–1289. [Google Scholar] [CrossRef]
  11. Tak, S.; Kumar, A. Chlorination disinfection by-products and comparative cost analysis of chlorination and UV disinfection in sewage treatment plants: Indian scenario. Environ. Sci. Pollut. Res. 2017, 24, 26269–26278. [Google Scholar] [CrossRef]
  12. Gallego Valero, L.; Moral Pajares, E.; Román Sánchez, I.M.; Sánchez Pérez, J.A. Analysis of Environmental Taxes to Finance Wastewater Treatment in Spain: An Opportunity for Regeneration? Water 2018, 10, 226. [Google Scholar] [CrossRef] [Green Version]
  13. Zhuang, Y.; Ren, H.; Geng, J.; Zhang, Y.; Zhang, Y.; Ding, L.; Xu, K. Inactivation of antibiotic resistance genes in municipal wastewater by chlorination, ultraviolet, and ozonation disinfection. Environ. Sci. Pollut. Res. 2015, 22, 7037–7044. [Google Scholar] [CrossRef] [PubMed]
  14. Walsh, T.; Mellor, J. Comparative life cycle assessment of four commonly used point-of-use water treatment technologies. J. Water Sanit. Hyg. Dev. 2020, 10, 862–873. [Google Scholar] [CrossRef]
  15. Pasqualino, J.C.; Meneses, M.; Castells, F. Life Cycle Assessment of Urban Wastewater Reclamation and Reuse Alternatives. J. Ind. Ecol. 2011, 15, 49–63. [Google Scholar] [CrossRef]
  16. Zhang, Y.; Zhuang, Y.; Geng, J.; Ren, H.; Xu, K.; Ding, L. Reduction of antibiotic resistance genes in municipal wastewater effluent by advanced oxidation processes. Sci. Total Environ. 2016, 550, 184–191. [Google Scholar] [CrossRef]
  17. Qiao, R.-P.; Li, N.; Qi, X.-H.; Wang, Q.-S.; Zhuang, Y.-Y. Degradation of microcystin-RR by UV radiation in the presence of hydrogen peroxide. Toxicon 2005, 45, 745–752. [Google Scholar] [CrossRef] [PubMed]
  18. Chin, A.; Bérubé, P.R. Removal of disinfection by-product precursors with ozone-UV advanced oxidation process. Water Res. 2005, 39, 2136–2144. [Google Scholar] [CrossRef] [PubMed]
  19. De la Cruz, N.; Esquius, L.; Grandjean, D.; Magnet, A.; Tungler, A.; de Alencastro, L.F.; Pulgarín, C. Degradation of emergent contaminants by UV, UV/H2O2 and neutral photo-Fenton at pilot scale in a domestic wastewater treatment plant. Water Res. 2013, 47, 5836–5845. [Google Scholar] [CrossRef]
  20. Guo, M.-T.; Yuan, Q.-B.; Yang, J. Ultraviolet reduction of erythromycin and tetracycline resistant heterotrophic bacteria and their resistance genes in municipal wastewater. Chemosphere 2013, 93, 2864–2868. [Google Scholar] [CrossRef]
  21. Zagklis, D.P.; Papageorgiou, C.S.; Paraskeva, C.A. 18—Valorization of phenolic extracts from Olea europaea L. by membrane operations. In Membrane Engineering in the Circular Economy: Renewable Sources Valorization in Energy and Downstream Processing in Agro-Food Industry; Iulianelli, A., Cassano, A., Conidi, C., Petrotos, K., Eds.; Elsevier: Amsterdam, The Netherlands, 2022; pp. 495–524. ISBN 978-0-323-85253-1. [Google Scholar]
  22. Urtiaga, A.M.; Pérez, G.; Ibáñez, R.; Ortiz, I. Removal of pharmaceuticals from a WWTP secondary effluent by ultrafiltration/reverse osmosis followed by electrochemical oxidation of the RO concentrate. Desalination 2013, 331, 26–34. [Google Scholar] [CrossRef]
  23. Cheng, H.; Hong, P.-Y. Removal of Antibiotic-Resistant Bacteria and Antibiotic Resistance Genes Affected by Varying Degrees of Fouling on Anaerobic Microfiltration Membranes. Environ. Sci. Technol. 2017, 51, 12200–12209. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Ren, S.; Boo, C.; Guo, N.; Wang, S.; Elimelech, M.; Wang, Y. Photocatalytic Reactive Ultrafiltration Membrane for Removal of Antibiotic Resistant Bacteria and Antibiotic Resistance Genes from Wastewater Effluent. Environ. Sci. Technol. 2018, 52, 8666–8673. [Google Scholar] [CrossRef] [PubMed]
  25. Dolar, D.; Ignjatić Zokić, T.; Košutić, K.; Ašperger, D.; Mutavdžić Pavlović, D. RO/NF membrane treatment of veterinary pharmaceutical wastewater: Comparison of results obtained on a laboratory and a pilot scale. Environ. Sci. Pollut. Res. 2012, 19, 1033–1042. [Google Scholar] [CrossRef] [PubMed]
  26. Ho, K.C.; Teoh, Y.X.; Teow, Y.H.; Mohammad, A.W. Life cycle assessment (LCA) of electrically-enhanced POME filtration: Environmental impacts of conductive-membrane formulation and process operating parameters. J. Environ. Manag. 2021, 277, 111434. [Google Scholar] [CrossRef]
  27. Pérez, G.; Gómez, P.; Ortiz, I.; Urtiaga, A. Techno-economic assessment of a membrane-based wastewater reclamation process. Desalination 2022, 522, 115409. [Google Scholar] [CrossRef]
  28. Zepon Tarpani, R.R.; Azapagic, A. Life cycle environmental impacts of advanced wastewater treatment techniques for removal of pharmaceuticals and personal care products (PPCPs). J. Environ. Manag. 2018, 215, 258–272. [Google Scholar] [CrossRef] [Green Version]
  29. Teow, Y.H.; Chong, M.T.; Ho, K.C.; Mohammad, A.W. Comparative environmental impact evaluation using life cycle assessment approach: A case study of integrated membrane-filtration system for the treatment of aerobically-digested palm oil mill effluent. Sustain. Environ. Res. 2021, 31, 15. [Google Scholar] [CrossRef]
  30. Vymazal, J. Constructed Wetlands for Wastewater Treatment. Water 2010, 2, 530–549. [Google Scholar] [CrossRef] [Green Version]
  31. Breitholtz, M.; Näslund, M.; Stråe, D.; Borg, H.; Grabic, R.; Fick, J. An evaluation of free water surface wetlands as tertiary sewage water treatment of micro-pollutants. Ecotoxicol. Environ. Saf. 2012, 78, 63–71. [Google Scholar] [CrossRef]
  32. Adrados, B.; Sánchez, O.; Arias, C.A.; Becares, E.; Garrido, L.; Mas, J.; Brix, H.; Morató, J. Microbial communities from different types of natural wastewater treatment systems: Vertical and horizontal flow constructed wetlands and biofilters. Water Res. 2014, 55, 304–312. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Younger, P.L.; Henderson, R. Synergistic wetland treatment of sewage and mine water: Pollutant removal performance of the first full-scale system. Water Res. 2014, 55, 74–82. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Huang, X.; Liu, C.; Li, K.; Su, J.; Zhu, G.; Liu, L. Performance of vertical up-flow constructed wetlands on swine wastewater containing tetracyclines and tet genes. Water Res. 2015, 70, 109–117. [Google Scholar] [CrossRef] [PubMed]
  35. Yi, X.; Tran, N.H.; Yin, T.; He, Y.; Gin, K.Y.-H. Removal of selected PPCPs, EDCs, and antibiotic resistance genes in landfill leachate by a full-scale constructed wetlands system. Water Res. 2017, 121, 46–60. [Google Scholar] [CrossRef]
  36. Fang, H.; Zhang, Q.; Nie, X.; Chen, B.; Xiao, Y.; Zhou, Q.; Liao, W.; Liang, X. Occurrence and elimination of antibiotic resistance genes in a long-term operation integrated surface flow constructed wetland. Chemosphere 2017, 173, 99–106. [Google Scholar] [CrossRef]
  37. Chen, J.; Ying, G.-G.; Wei, X.-D.; Liu, Y.-S.; Liu, S.-S.; Hu, L.-X.; He, L.-Y.; Chen, Z.-F.; Chen, F.-R.; Yang, Y.-Q. Removal of antibiotics and antibiotic resistance genes from domestic sewage by constructed wetlands: Effect of flow configuration and plant species. Sci. Total Environ. 2016, 571, 974–982. [Google Scholar] [CrossRef]
  38. Liu, L.; Liu, C.; Zheng, J.; Huang, X.; Wang, Z.; Liu, Y.; Zhu, G. Elimination of veterinary antibiotics and antibiotic resistance genes from swine wastewater in the vertical flow constructed wetlands. Chemosphere 2013, 91, 1088–1093. [Google Scholar] [CrossRef]
  39. Nõlvak, H.; Truu, M.; Tiirik, K.; Oopkaup, K.; Sildvee, T.; Kaasik, A.; Mander, Ü.; Truu, J. Dynamics of antibiotic resistance genes and their relationships with system treatment efficiency in a horizontal subsurface flow constructed wetland. Sci. Total Environ. 2013, 461–462, 636–644. [Google Scholar] [CrossRef]
  40. Chen, J.; Wei, X.-D.; Liu, Y.-S.; Ying, G.-G.; Liu, S.-S.; He, L.-Y.; Su, H.-C.; Hu, L.-X.; Chen, F.-R.; Yang, Y.-Q. Removal of antibiotics and antibiotic resistance genes from domestic sewage by constructed wetlands: Optimization of wetland substrates and hydraulic loading. Sci. Total Environ. 2016, 565, 240–248. [Google Scholar] [CrossRef]
  41. Huang, X.; Zheng, J.; Liu, C.; Liu, L.; Liu, Y.; Fan, H. Removal of antibiotics and resistance genes from swine wastewater using vertical flow constructed wetlands: Effect of hydraulic flow direction and substrate type. Chem. Eng. J. 2017, 308, 692–699. [Google Scholar] [CrossRef]
  42. Casas Ledón, Y.; Rivas, A.; López, D.; Vidal, G. Life-cycle greenhouse gas emissions assessment and extended exergy accounting of a horizontal-flow constructed wetland for municipal wastewater treatment: A case study in Chile. Ecol. Indic. 2017, 74, 130–139. [Google Scholar] [CrossRef]
  43. Corbella, C.; Puigagut, J.; Garfí, M. Life cycle assessment of constructed wetland systems for wastewater treatment coupled with microbial fuel cells. Sci. Total Environ. 2017, 584–585, 355–362. [Google Scholar] [CrossRef] [PubMed]
  44. Flores, L.; García, J.; Pena, R.; Garfí, M. Constructed wetlands for winery wastewater treatment: A comparative Life Cycle Assessment. Sci. Total Environ. 2019, 659, 1567–1576. [Google Scholar] [CrossRef] [PubMed]
  45. Resende, J.D.; Nolasco, M.A.; Pacca, S.A. Life cycle assessment and costing of wastewater treatment systems coupled to constructed wetlands. Resour. Conserv. Recycl. 2019, 148, 170–177. [Google Scholar] [CrossRef]
  46. Lakho, F.H.; Qureshi, A.; Igodt, W.; Le, H.Q.; Depuydt, V.; Rousseau, D.P.L.; Van Hulle, S.W.H. Life cycle assessment of two decentralized water treatment systems combining a constructed wetland and a membrane based drinking water production system. Resour. Conserv. Recycl. 2022, 178, 106104. [Google Scholar] [CrossRef]
  47. Pan, T.; Zhu, X.-D.; Ye, Y.-P. Estimate of life-cycle greenhouse gas emissions from a vertical subsurface flow constructed wetland and conventional wastewater treatment plants: A case study in China. Ecol. Eng. 2011, 37, 248–254. [Google Scholar] [CrossRef]
  48. Lutterbeck, C.A.; Kist, L.T.; Lopez, D.R.; Zerwes, F.V.; Machado, Ê.L. Life cycle assessment of integrated wastewater treatment systems with constructed wetlands in rural areas. J. Clean. Prod. 2017, 148, 527–536. [Google Scholar] [CrossRef]
  49. Garfí, M.; Flores, L.; Ferrer, I. Life Cycle Assessment of wastewater treatment systems for small communities: Activated sludge, constructed wetlands and high rate algal ponds. J. Clean. Prod. 2017, 161, 211–219. [Google Scholar] [CrossRef]
  50. Magalhães, I.B.; Ferreira, J.; de Castro, J.S.; de Assis, L.R.; Calijuri, M.L. Agro-industrial wastewater-grown microalgae: A techno-environmental assessment of open and closed systems. Sci. Total Environ. 2022, 834, 155282. [Google Scholar] [CrossRef]
  51. Silambarasan, S.; Logeswari, P.; Sivaramakrishnan, R.; Incharoensakdi, A.; Cornejo, P.; Kamaraj, B.; Chi, N.T.L. Removal of nutrients from domestic wastewater by microalgae coupled to lipid augmentation for biodiesel production and influence of deoiled algal biomass as biofertilizer for Solanum lycopersicum cultivation. Chemosphere 2021, 268, 129323. [Google Scholar] [CrossRef]
  52. Marangon, B.B.; Calijuri, M.L.; de Siqueira Castro, J.; Assemany, P.P. A life cycle assessment of energy recovery using briquette from wastewater grown microalgae biomass. J. Environ. Manag. 2021, 285, 112171. [Google Scholar] [CrossRef] [PubMed]
  53. Li, P.; Luo, Y.; Yuan, X. Life cycle and techno-economic assessment of source-separated wastewater-integrated microalgae biofuel production plant: A nutrient organization approach. Bioresour. Technol. 2022, 344, 126230. [Google Scholar] [CrossRef] [PubMed]
  54. Wang, J.; Chen, H. Catalytic ozonation for water and wastewater treatment: Recent advances and perspective. Sci. Total Environ. 2020, 704, 135249. [Google Scholar] [CrossRef] [PubMed]
  55. Lamba, M.; Ahammad, S.Z. Performance comparison of secondary and tertiary treatment systems for treating antibiotic resistance. Water Res. 2017, 127, 172–182. [Google Scholar] [CrossRef]
  56. Nasuhoglu, D.; Isazadeh, S.; Westlund, P.; Neamatallah, S.; Yargeau, V. Chemical, microbial and toxicological assessment of wastewater treatment plant effluents during disinfection by ozonation. Chem. Eng. J. 2018, 346, 466–476. [Google Scholar] [CrossRef]
  57. Shi, Q.; Chen, Z.; Liu, H.; Lu, Y.; Li, K.; Shi, Y.; Mao, Y.; Hu, H.-Y. Efficient synergistic disinfection by ozone, ultraviolet irradiation and chlorine in secondary effluents. Sci. Total Environ. 2021, 758, 143641. [Google Scholar] [CrossRef]
  58. Maniakova, G.; Salmerón, I.; Nahim-Granados, S.; Malato, S.; Oller, I.; Rizzo, L.; Polo-López, M.I. Sunlight advanced oxidation processes vs ozonation for wastewater disinfection and safe reclamation. Sci. Total Environ. 2021, 787, 147531. [Google Scholar] [CrossRef]
  59. Liu, Z.; Chys, M.; Yang, Y.; Demeestere, K.; Van Hulle, S. Oxidation of Trace Organic Contaminants (TrOCs) in Wastewater Effluent with Different Ozone-Based AOPs: Comparison of Ozone Exposure and •OH Formation. Ind. Eng. Chem. Res. 2019, 58, 8896–8902. [Google Scholar] [CrossRef]
  60. Antoniou, M.G.; Hey, G.; Rodríguez Vega, S.; Spiliotopoulou, A.; Fick, J.; Tysklind, M.; la Cour Jansen, J.; Andersen, H.R. Required ozone doses for removing pharmaceuticals from wastewater effluents. Sci. Total Environ. 2013, 456–457, 42–49. [Google Scholar] [CrossRef] [Green Version]
  61. Chys, M.; Audenaert, W.T.M.; Stapel, H.; Ried, A.; Wieland, A.; Weemaes, M.; Van Langenhove, H.; Nopens, I.; Demeestere, K.; Van Hulle, S.W.H. Techno-economic assessment of surrogate-based real-time control and monitoring of secondary effluent ozonation at pilot scale. Chem. Eng. J. 2018, 352, 431–440. [Google Scholar] [CrossRef]
  62. Pérez-Moya, M.; Graells, M.; Castells, G.; Amigó, J.; Ortega, E.; Buhigas, G.; Pérez, L.M.; Mansilla, H.D. Characterization of the degradation performance of the sulfamethazine antibiotic by photo-Fenton process. Water Res. 2010, 44, 2533–2540. [Google Scholar] [CrossRef]
  63. Trovó, A.G.; Pupo Nogueira, R.F.; Agüera, A.; Fernandez-Alba, A.R.; Malato, S. Degradation of the antibiotic amoxicillin by photo-Fenton process—Chemical and toxicological assessment. Water Res. 2011, 45, 1394–1402. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Giannakis, S.; Le, T.-T.M.; Entenza, J.M.; Pulgarin, C. Solar photo-Fenton disinfection of 11 antibiotic-resistant bacteria (ARB) and elimination of representative AR genes. Evidence that antibiotic resistance does not imply resistance to oxidative treatment. Water Res. 2018, 143, 334–345. [Google Scholar] [CrossRef] [PubMed]
  65. Miralles-Cuevas, S.; Oller, I.; Ruiz Aguirre, A.; Sánchez Pérez, J.A.; Malato Rodríguez, S. Removal of pharmaceuticals at microg L−1 by combined nanofiltration and mild solar photo-Fenton. Chem. Eng. J. 2014, 239, 68–74. [Google Scholar] [CrossRef]
  66. Elmolla, E.S.; Chaudhuri, M. Combined photo-Fenton–SBR process for antibiotic wastewater treatment. J. Hazard. Mater. 2011, 192, 1418–1426. [Google Scholar] [CrossRef]
  67. Rodríguez, R.; Espada, J.J.; Pariente, M.I.; Melero, J.A.; Martínez, F.; Molina, R. Comparative life cycle assessment (LCA) study of heterogeneous and homogenous Fenton processes for the treatment of pharmaceutical wastewater. J. Clean. Prod. 2016, 124, 21–29. [Google Scholar] [CrossRef]
  68. Pesqueira, J.F.J.R.; Pereira, M.F.R.; Silva, A.M.T. A life cycle assessment of solar-based treatments (H2O2, TiO2 photocatalysis, circumneutral photo-Fenton) for the removal of organic micropollutants. Sci. Total Environ. 2021, 761, 143258. [Google Scholar] [CrossRef]
  69. Gallego-Schmid, A.; Tarpani, R.R.Z.; Miralles-Cuevas, S.; Cabrera-Reina, A.; Malato, S.; Azapagic, A. Environmental assessment of solar photo-Fenton processes in combination with nanofiltration for the removal of micro-contaminants from real wastewaters. Sci. Total Environ. 2019, 650, 2210–2220. [Google Scholar] [CrossRef]
  70. Foteinis, S.; Monteagudo, J.M.; Durán, A.; Chatzisymeon, E. Environmental sustainability of the solar photo-Fenton process for wastewater treatment and pharmaceuticals mineralization at semi-industrial scale. Sci. Total Environ. 2018, 612, 605–612. [Google Scholar] [CrossRef] [Green Version]
  71. Belalcázar-Saldarriaga, A.; Prato-Garcia, D.; Vasquez-Medrano, R. Photo-Fenton processes in raceway reactors: Technical, economic, and environmental implications during treatment of colored wastewaters. J. Clean. Prod. 2018, 182, 818–829. [Google Scholar] [CrossRef]
  72. Hey, G.; Ledin, A.; la Cour Jansen, J.; Andersen, H.R. Removal of pharmaceuticals in biologically treated wastewater by chlorine dioxide or peracetic acid. Environ. Technol. 2012, 33, 1041–1047. [Google Scholar] [CrossRef] [PubMed]
  73. Akhoundi, A.; Nazif, S. Life-cycle assessment of tertiary treatment technologies to treat secondary municipal wastewater for reuse in agricultural irrigation, artificial recharge of groundwater, and industrial usages. J. Environ. Eng. 2020, 146, 4020031. [Google Scholar] [CrossRef]
  74. Licciardello, F.; Milani, M.; Consoli, S.; Pappalardo, N.; Barbagallo, S.; Cirelli, G. Wastewater tertiary treatment options to match reuse standards in agriculture. Agric. Water Manag. 2018, 210, 232–242. [Google Scholar] [CrossRef]
  75. Kim, I.; Yamashita, N.; Tanaka, H. Performance of UV and UV/H2O2 processes for the removal of pharmaceuticals detected in secondary effluent of a sewage treatment plant in Japan. J. Hazard. Mater. 2009, 166, 1134–1140. [Google Scholar] [CrossRef]
  76. Yang, W.; Zhou, H.; Cicek, N. Treatment of Organic Micropollutants in Water and Wastewater by UV-Based Processes: A Literature Review. Crit. Rev. Environ. Sci. Technol. 2014, 44, 1443–1476. [Google Scholar] [CrossRef]
  77. Carré, E.; Beigbeder, J.; Jauzein, V.; Junqua, G.; Lopez-Ferber, M. Life cycle assessment case study: Tertiary treatment process options for wastewater reuse. Integr. Environ. Assess. Manag. 2017, 13, 1113–1121. [Google Scholar] [CrossRef]
  78. Ganiyu, S.O.; van Hullebusch, E.D.; Cretin, M.; Esposito, G.; Oturan, M.A. Coupling of membrane filtration and advanced oxidation processes for removal of pharmaceutical residues: A critical review. Sep. Purif. Technol. 2015, 156, 891–914. [Google Scholar] [CrossRef]
  79. Chen, J.; Liu, Y.-S.; Su, H.-C.; Ying, G.-G.; Liu, F.; Liu, S.-S.; He, L.-Y.; Chen, Z.-F.; Yang, Y.-Q.; Chen, F.-R. Removal of antibiotics and antibiotic resistance genes in rural wastewater by an integrated constructed wetland. Environ. Sci. Pollut. Res. 2015, 22, 1794–1803. [Google Scholar] [CrossRef]
  80. Cardinal, P.; Anderson, J.C.; Carlson, J.C.; Low, J.E.; Challis, J.K.; Beattie, S.A.; Bartel, C.N.; Elliott, A.D.; Montero, O.F.; Lokesh, S.; et al. Macrophytes may not contribute significantly to removal of nutrients, pharmaceuticals, and antibiotic resistance in model surface constructed wetlands. Sci. Total Environ. 2014, 482–483, 294–304. [Google Scholar] [CrossRef]
  81. Kong, Q.; Li, L.; Martinez, B.; Chen, P.; Ruan, R. Culture of Microalgae Chlamydomonas reinhardtii in Wastewater for Biomass Feedstock Production. Appl. Biochem. Biotechnol. 2009, 160, 9. [Google Scholar] [CrossRef]
  82. Ansari, F.A.; Ravindran, B.; Gupta, S.K.; Nasr, M.; Rawat, I.; Bux, F. Techno-economic estimation of wastewater phycoremediation and environmental benefits using Scenedesmus obliquus microalgae. J. Environ. Manag. 2019, 240, 293–302. [Google Scholar] [CrossRef] [PubMed]
  83. Salama, E.-S.; Abou-Shanab, R.A.I.; Kim, J.R.; Lee, S.; Kim, S.-H.; Oh, S.-E.; Kim, H.-C.; Roh, H.-S.; Jeon, B.-H. The effects of salinity on the growth and biochemical properties of Chlamydomonas mexicana GU732420 cultivated in municipal wastewater. Environ. Technol. 2014, 35, 1491–1498. [Google Scholar] [CrossRef] [PubMed]
  84. Hena, S.; Gutierrez, L.; Croué, J.-P. Removal of pharmaceutical and personal care products (PPCPs) from wastewater using microalgae: A review. J. Hazard. Mater. 2021, 403, 124041. [Google Scholar] [CrossRef] [PubMed]
  85. Chaudry, S. Integrating Microalgae Cultivation with Wastewater Treatment: A Peek into Economics. Appl. Biochem. Biotechnol. 2021, 193, 3395–3406. [Google Scholar] [CrossRef]
  86. De Schneider, R.C.S.; de Moura Lima, M.; Hoeltz, M.; de Farias Neves, F.; John, D.K.; de Azevedo, A. Life cycle assessment of microalgae production in a raceway pond with alternative culture media. Algal Res. 2018, 32, 280–292. [Google Scholar] [CrossRef]
  87. Igos, E.; Mailler, R.; Guillossou, R.; Rocher, V.; Gasperi, J. Life cycle assessment of powder and micro-grain activated carbon in a fluidized bed to remove micropollutants from wastewater and their comparison with ozonation. J. Clean. Prod. 2021, 287, 125067. [Google Scholar] [CrossRef]
  88. Arzate, S.; Pfister, S.; Oberschelp, C.; Sánchez-Pérez, J.A. Environmental impacts of an advanced oxidation process as tertiary treatment in a wastewater treatment plant. Sci. Total Environ. 2019, 694, 133572. [Google Scholar] [CrossRef]
  89. Muñoz, I.; Rodríguez, A.; Rosal, R.; Fernández-Alba, A.R. Life Cycle Assessment of urban wastewater reuse with ozonation as tertiary treatment: A focus on toxicity-related impacts. Sci. Total Environ. 2009, 407, 1245–1256. [Google Scholar] [CrossRef]
  90. Sánchez Pérez, J.A.; Arzate, S.; Soriano-Molina, P.; García Sánchez, J.L.; Casas López, J.L.; Plaza-Bolaños, P. Neutral or acidic pH for the removal of contaminants of emerging concern in wastewater by solar photo-Fenton? A techno-economic assessment of continuous raceway pond reactors. Sci. Total Environ. 2020, 736, 139681. [Google Scholar] [CrossRef]
Figure 1. Normalized scores for the three aspects examined for each tertiary treatment method; (a) technical aspect, (b) economic aspect, (c) life cycle aspect.
Figure 1. Normalized scores for the three aspects examined for each tertiary treatment method; (a) technical aspect, (b) economic aspect, (c) life cycle aspect.
Processes 10 02304 g001aProcesses 10 02304 g001b
Figure 2. Ternary diagram for the evaluation of tertiary treatment methods, with an example of 0.2, 0.6, and 0.2 weights for the technical, economic, and life cycle aspects, respectively.
Figure 2. Ternary diagram for the evaluation of tertiary treatment methods, with an example of 0.2, 0.6, and 0.2 weights for the technical, economic, and life cycle aspects, respectively.
Processes 10 02304 g002
Table 1. Average technical economic and life cycle performances of the examined tertiary treatment methods.
Table 1. Average technical economic and life cycle performances of the examined tertiary treatment methods.
CategoryTreatment MethodTechnicalEconomic
(Cost EUR/m3)
Life Cycle
(kg CO2 eq. m−3)
Microbial
(Log Reduction)
Nutrients
(% Reduction)
Pharmaceuticals
(% Reduction)
PhysicochemicalChlorination2.140420.0040.040
UV2.920530.0040.086
Membrane filtration3.506700.6140.754
BiologicalConstructed wetlands0.8753570.7840.511
Microalgae0.0077730.2910.468
Advanced oxidationOzonation3.180630.0300.219
Photo-Fenton4.930840.4050.549
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Zagklis, D.P.; Bampos, G. Tertiary Wastewater Treatment Technologies: A Review of Technical, Economic, and Life Cycle Aspects. Processes 2022, 10, 2304. https://doi.org/10.3390/pr10112304

AMA Style

Zagklis DP, Bampos G. Tertiary Wastewater Treatment Technologies: A Review of Technical, Economic, and Life Cycle Aspects. Processes. 2022; 10(11):2304. https://doi.org/10.3390/pr10112304

Chicago/Turabian Style

Zagklis, Dimitris P., and Georgios Bampos. 2022. "Tertiary Wastewater Treatment Technologies: A Review of Technical, Economic, and Life Cycle Aspects" Processes 10, no. 11: 2304. https://doi.org/10.3390/pr10112304

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop